v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating activities:    
Net loss $ (31,539) $ (91,362)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 873 1,475
Amortization of identified intangible assets 2,677 3,358
Amortization of deferred loan origination costs 81 102
Amortization of deferred sales commissions 2,312 1,368
Non-cash lease expense 1,369 1,207
Stock-based compensation expense 8,878 1,458
Equity incentive bonus 0 32,863
Bad debt expense 373 110
Loss on disposition of asset 13 0
Deferred income tax benefit (133) (272)
Loss on sale of marketable securities 42 0
Amortization of premium paid on marketable securities 346 0
Change in the fair value of warrant liability (134) (675)
Offering cost associated with Warrants recorded as liabilities 0 41
Changes in assets and liabilities    
Accounts receivable (498) (2,648)
Other assets 1,249 (2,514)
Deferred sales commissions (3,340) (5,347)
Accounts payable (2,369) 1,725
Accrued expenses (1,945) 1,225
Deferred revenue (71) (54)
Operating lease liabilities (1,467) (1,202)
Other long-term liabilities 0 (2)
Net cash used in operating activities (23,283) (59,144)
Investing activities:    
Purchases of property and equipment (880) (1,210)
Purchases of marketable securities (9,459) 0
Proceeds from sale of marketable securities 3,451 0
Proceeds from maturities and principal paydowns of marketable securities 5,961 0
Proceeds from asset acquisition, net of cash paid 0 1,326
Net cash provided by (used in) investing activities (927) 116
Financing activities:    
Proceeds from Merger and PIPE financing, net of cash paid 0 157,383
Repayments on loan payable (421) (1,676)
Repayments of drawdown on line of credit 0 (4,672)
Debt issuance costs 0 (153)
Payments of contingent consideration liability 0 (5,969)
Repayments on finance lease obligations (19) (331)
Payments of employees’ withholding taxes on net share settlement of share-based awards (513) 0
Proceeds from the structured payable arrangement 1,311 0
Principal payments under the structured payable arrangement (435) 0
Net cash provided by (used in) financing activities (77) 144,582
Effect of foreign currency translation (336) (40)
Net increase (decrease) in cash, cash equivalents and restricted cash (24,623) 85,514
Cash, cash equivalents, and restricted cash beginning of period 47,317 19,566
Cash, cash equivalents, and restricted cash end of period 22,694 105,080
Supplemental disclosure of cash flow information:    
Interest paid 2,619 2,828
Income taxes paid 345 237
Supplemental schedule of noncash investing activities:    
Change in unrealized loss on marketable securities 1,492 0
Additional right-of-use assets 1,261 3,246
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents:    
Cash and cash equivalents 22,594 104,980
Restricted cash, current 100 0
Restricted cash, net of current 0 100
Total cash, cash equivalents and restricted cash $ 22,694 $ 105,080

Source